Literature DB >> 9529346

The African origin of the common mutation in African American patients with glycogen-storage disease type II.

J A Becker, J Vlach, N Raben, K Nagaraju, E M Adams, M M Hermans, A J Reuser, S S Brooks, C J Tifft, R Hirschhorn, M L Huie, M Nicolino, P H Plotz.   

Abstract

Entities:  

Mesh:

Year:  1998        PMID: 9529346      PMCID: PMC1377028          DOI: 10.1086/301788

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  21 in total

1.  Pompe disease in a Brazilian series: clinical and molecular analyses with identification of nine new mutations.

Authors:  Sueli M Oba-Shinjo; Roseli da Silva; Fernanda G Andrade; Rachel E Palmer; Robert J Pomponio; Kristina M Ciociola; Mary S Carvalho; Paulo S Gutierrez; Gilda Porta; Carlo D Marrone; Verônica Munoz; Anderson K Grzesiuk; Juan C Llerena; Célia R Berditchevsky; Claudia Sobreira; Dafne Horovitz; Thamine P Hatem; Elizabeth R C Frota; Rogerio Pecchini; João Aris Kouyoumdjian; Lineu Werneck; Veronica M Amado; José S Camelo; Robert J Mattaliano; Suely K N Marie
Journal:  J Neurol       Date:  2009-07-09       Impact factor: 4.849

2.  Identification and Functional Characterization of GAA Mutations in Colombian Patients Affected by Pompe Disease.

Authors:  Mónica Yasmín Niño; Heidi Eliana Mateus; Dora Janeth Fonseca; Marian A Kroos; Sandra Yaneth Ospina; Juan Fernando Mejía; Jesús Alfredo Uribe; Arnold J J Reuser; Paul Laissue
Journal:  JIMD Rep       Date:  2012-04-19

Review 3.  Molecular genetics of Pompe disease: a comprehensive overview.

Authors:  Paolo Peruzzo; Eleonora Pavan; Andrea Dardis
Journal:  Ann Transl Med       Date:  2019-07

Review 4.  Pompe Disease: From Basic Science to Therapy.

Authors:  Lara Kohler; Rosa Puertollano; Nina Raben
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

Review 5.  The dynamic life of the glycogen granule.

Authors:  Clara Prats; Terry E Graham; Jane Shearer
Journal:  J Biol Chem       Date:  2018-02-26       Impact factor: 5.157

6.  Clinical and GAA gene mutation analysis in mainland Chinese patients with late-onset Pompe disease: identifying c.2238G > C as the most common mutation.

Authors:  Xiao Liu; Zhaoxia Wang; Weina Jin; He Lv; Wei Zhang; Chengli Que; Yu Huang; Yun Yuan
Journal:  BMC Med Genet       Date:  2014-12-20       Impact factor: 2.103

7.  A novel homozygous mutation at the GAA gene in Mexicans with early-onset Pompe disease.

Authors:  Carmen Esmer; Rosario Becerra-Becerra; Claudia Peña-Zepeda; Antonio Bravo-Oro
Journal:  Acta Myol       Date:  2013-10

Review 8.  Pompe disease: from pathophysiology to therapy and back again.

Authors:  Jeong-A Lim; Lishu Li; Nina Raben
Journal:  Front Aging Neurosci       Date:  2014-07-23       Impact factor: 5.750

9.  Clinical Laboratory Experience of Blood CRIM Testing in Infantile Pompe Disease.

Authors:  Deeksha S Bali; Jennifer L Goldstein; Catherine Rehder; Zoheb B Kazi; Kathryn L Berrier; Jian Dai; Priya S Kishnani
Journal:  Mol Genet Metab Rep       Date:  2015-12-01

Review 10.  Infantile-onset Pompe disease with neonatal debut: A case report and literature review.

Authors:  Miriam Martínez; Mar García Romero; Luis García Guereta; Marta Cabrera; Rita M Regojo; Luis Albajara; Maria L Couce; Miguel Saenz de Pipaon
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.